Media coverage
J.P. Morgan Roundtable: Financing Challenges, And Opportunities, For Complex Therapies
Mandy.Jackson@informausa.com
Executive Summary
Part 1: Scrip spoke with companies working on cell and gene therapies and novel neuroscience platforms – areas difficult to finance in the past, but seeing increasing investor interest – about funding challenges and opportunities in 2019.
(continue reading: https://scrip.pharmaintelligence.informa.com/SC124600/JP-Morgan-Roundtable-Financing-Challenges-And-Opportunities-For-Complex-Therapies)